SEC Comment Letter for PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081) (PTCT) — Feb 19, 2016
PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081)
Date: Feb. 19, 2016 · CIK: 0001070081 · Accession: 0000000000-16-065576
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-35969
Letter
Mail Stop 4720 February 19, 201 6 Via E -mail Mr. Shane Kovacs Chief Financial Officer PTC Therapeutics, Inc. 100 Corporate Court South Plainfield, New Jersey 07080
Re: PTC Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 201 4 Filed March 2 , 2015 File No. 001-35969
Dear Mr. Kovacs :
We have completed our review of your filing. We remind you that our comments or changes to disclosu re in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the compa ny may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the feder al securities laws of the United States . We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable ru les require.
Sincerely,
/s/ Sharon M. Blume
Show Raw Text
Mail Stop 4720 February 19, 201 6 Via E -mail Mr. Shane Kovacs Chief Financial Officer PTC Therapeutics, Inc. 100 Corporate Court South Plainfield, New Jersey 07080 Re: PTC Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 201 4 Filed March 2 , 2015 File No. 001-35969 Dear Mr. Kovacs : We have completed our review of your filing. We remind you that our comments or changes to disclosu re in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the compa ny may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the feder al securities laws of the United States . We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable ru les require. Sincerely, /s/ Sharon M. Blume Sharon M. Blume Accounting Branch Chief Office of Healthcare and Insurance